Likes Subject
NK cells, ICE engagers, even CART etc. all NY1972 11/30/22 4:59 PM
New preclinical data https://www.nature.com/articles/s41467-022-35127-2 jondoeuk 11/29/22 9:57 PM
If you look at past history, it hasn't jondoeuk 11/29/22 9:50 PM
No TAM flipper or TME drug will show NY1972 11/19/22 10:10 PM
Testing a triplet makes sense. So, AFM24, an jondoeuk 11/19/22 3:22 PM
Targeting SIRPa was targeted when CD47 mAbs were NY1972 11/18/22 4:11 PM
I wonder if targeting SIRPa (or other checkpoints) jondoeuk 11/17/22 6:39 PM
Most are going that route, including them. When jondoeuk 11/17/22 6:31 PM
What is your opinion on AFM24 + NY1972 11/07/22 6:14 PM
Off target editing will be a headache for NY1972 11/06/22 5:16 PM
I wasn't aware of Artiva. They are starting jondoeuk 11/06/22 3:38 PM
From memory, the ORRs for anti-CD19 CARs, be jondoeuk 11/05/22 2:41 PM
Strange the most striking ASH data is from NY1972 11/03/22 11:45 PM
ASH abstract jondoeuk 11/03/22 8:03 PM
ASH abstracts jondoeuk 11/03/22 2:06 PM
ASH abstracts jondoeuk 11/03/22 1:44 PM
(OT): Augmenting CAR NK cell Anti-tumor Activity by jondoeuk 11/01/22 5:53 PM
You can read the paper here https://www.biorxiv.org/content/10.1101/2021.12.17.4 jondoeuk 10/25/22 5:40 PM
(OT) New preclinical data https://www.sciencedaily.com/releases/2022/10/22102511 jondoeuk 10/25/22 5:32 PM
(OT) https://www.globenewswire.com/en/news-release/2022/10/17/2535490/0/en/Etern jondoeuk 10/17/22 1:38 PM
(OT) NKILT Therapeutics is developing a novel approach jondoeuk 10/12/22 7:25 PM
(OT) Dr. Crooks is a co-founder of a jondoeuk 10/10/22 2:11 PM
I can't see any potential breakthroughs until at jondoeuk 10/07/22 4:04 PM
SITC titles jondoeuk 10/07/22 3:16 PM
From FB https://www.fiercebiotech.com/biotech/allogene-gets-green-light-pivotal- jondoeuk 10/07/22 2:41 PM
Tumors have too many body guards. NY1972 10/04/22 8:04 PM
allo carts need to make a breakthrough to NY1972 10/01/22 11:04 PM
ALLO's pivotal trial will be in 3+ line jondoeuk 09/30/22 4:19 PM
With NVS 2 day AUTO cell therapy, ALLO NY1972 09/29/22 9:06 PM
(OT) A report on two patients with chemotherapy jondoeuk 09/29/22 2:09 PM
(OT) Overcoming trogocytosis* mediated fratricide of NK cells jondoeuk 09/29/22 2:03 PM
No, but I look forward to clinical data jondoeuk 09/28/22 8:01 PM
Are you expecting any NK or T cell NY1972 09/17/22 11:57 PM
They could present FT500/516 data at SITC, but jondoeuk 09/15/22 8:23 PM
With J&J's Janssen, all four antigen targets have jondoeuk 09/14/22 8:45 PM
In addition, there will also be a comprehensive jondoeuk 09/14/22 8:45 PM
During this half, they will take the opportunity jondoeuk 09/14/22 8:43 PM
(OT) Two interesting upcoming conferences https://ncifrederick.cancer.gov/events jondoeuk 09/07/22 7:19 PM
(OT) From this, ''Dr. Wang commented: "In as jondoeuk 09/07/22 3:13 PM
Maybe they were all too busy focusing on jondoeuk 09/07/22 2:06 PM
More data will lead to more questions from NY1972 08/30/22 4:09 PM
It turns out that the FDA's concerns about jondoeuk 08/30/22 2:29 PM
ONKT104 is an anti-CLL-1 (+/- a second CAR) jondoeuk 08/29/22 2:31 PM
(OT) New preclinical data on ONKT102, an anti-CD38 jondoeuk 08/28/22 2:30 PM
No, but it is listed in the recent jondoeuk 08/26/22 2:48 PM
DTIL no longer mentioned foralumab. I think maintaining NY1972 08/24/22 9:34 PM
Another issue for them long-term is the fact jondoeuk 08/24/22 6:58 PM
More allogenic = less cytotoxic. It is a NY1972 08/21/22 9:08 PM
Not a million miles from what BEAM is jondoeuk 08/20/22 5:27 PM
Diorio et al demonstrate that base editing enabled NY1972 08/16/22 9:20 PM
Likes Subject

jondoeuk
11/29/22 9:50 PM
NY1972
11/19/22 10:10 PM
NY1972
11/07/22 6:14 PM
jondoeuk
11/03/22 8:03 PM
jondoeuk
11/03/22 2:06 PM
jondoeuk
11/03/22 1:44 PM
jondoeuk
10/10/22 2:11 PM
jondoeuk
10/07/22 3:16 PM
NY1972
10/04/22 8:04 PM
jondoeuk
09/30/22 4:19 PM
NY1972
09/29/22 9:06 PM
jondoeuk
09/28/22 8:01 PM
NY1972
09/17/22 11:57 PM
jondoeuk
09/07/22 2:06 PM
jondoeuk
08/30/22 2:29 PM
jondoeuk
08/26/22 2:48 PM
jondoeuk
08/20/22 5:27 PM

Fate Therapeutics Inc. (FATE)

Followers
19
Posters
33
Posts (Today)
0
Posts (Total)
201
Created
10/30/13
Type
Free
Moderators jondoeuk
Most Liked Posts
(Last 30 Days)
New Post